Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like Flex Pharma To Report Second Quarter 2017 Results On August 2, 2017 July 25, 2017 The Alliance for Regenerative Medicine (ARM) Releases Q2 2017 Data Report, Highlighting Sector Trends And Metrics August 17, 2017 Imprimis Announces First Quarter 2017 Financial Results May 10, 2017
The Alliance for Regenerative Medicine (ARM) Releases Q2 2017 Data Report, Highlighting Sector Trends And Metrics August 17, 2017